Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 4 A SPEC. ISSUE, 1997, Pages 573-577

  Popiela, Tadeusz ^a   Kulig, Jan ^a   Karcz, Danuta ^a   Tabor, Jacek ^a   Torres, Jesús ^b   Márquez, Miguel ^b   Fillat, Oscar ^b   Herrero, Eduardo ^b   Ortiz, José A ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

Amoxicillin; CAS 100981 43 9; Ebrotidine; FI 3542, combination with antibiotics, duodenal ulcer healing rate, H. pylori eradication; H2 Receptor antagonist; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; EBROTIDINE; RANITIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUODENUM ULCER; ENDOSCOPY; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PROTECTION; TREATMENT PLANNING;

ADULT; AMOXICILLIN; BENZENESULFONATES; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RANITIDINE; THIAZOLES;

EID: 0030958006     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anglada, L., Márquez, M., Sacristán, A. et al., Eur. J. Med. Chem. 23, 97 (1988)
2. Konturek, S. J., Brzozowski, T., Drozdowicz, D. et al., Eur. J. Gastroenterol. Hepatol. 3, 941 (1991)
3. Maczka, M., Kwiecien, N., Obtulovicz, W. et al., J. Physiol. Pharmacol. 43, 139 (1992)
4. Konturek, S. J., Maczka, K., Kaminski, E. et al., Scand. J. Gastroenterol. 27, 438 (1992)
5. Muñoz, M., Taxonera, C., Val, J. et al., Continuous intragastric pH monitoring in the evaluation of the effect of a dose of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers. First United European Gastroenterology Week, Athens 1992
6. Brzozowski, T., Majka, J., Konturek, S. J., Digestion 51, 27 (1992)
7. Slomiany, B. L., Piotrowski, J., Murty, V. L. N. et al., Gen. Pharmacol. 23, 719 (1992)
8. Slomiany, B. L., Piotrowski, J., Mojtahed, H. et al., Gen. Pharmacol. 23, 203 (1992)
9. Slomiany, B. L., Piotrowski, J., Murty, V. L. N. et al., Gen. Pharmacol. 26, 1553 (1995)
10. Piotrowski, J., Slomiany, A., Slomiany, B. L., Biochem. Mol. Biol. Int. 37, 247 (1995)
11. Piotrowski, J., Piotrowski, E., Slomiany, A. et al., J. Physiol. Pharmacol. 46, 463 (1995)
12. Marshall, B. J., Armstrong, J. A., Graham, J. F. et al., Digestion 37 (Suppl. 2), 16 (1987)
13. Borsch, G., Adamek, R., Sandmann, M. et al., Hepatogastroenterology 34, 236 (1987)
14. Piotrowski, J., Morita, M., Slomiany, A. et al., Biochem. Int. 27, 131 (1992)
15. Piotrowski, J., Slomiany, A., Slomiany, B. L., Biochem. Mol. Biol. Int. 31, 1051 (1993)
16. Graham, D. Y., Ginger, M. L., Evans, D. G. et al., Ann. Intern. Med. 115, 266 (1991)
17. Rauws, E. A. J., Tytgat, G. N. J., Lancet 335, 1233 (1990)
18. Borody, T. J., Cole, P., Noonan, S., Med. J. Aust. 151, 431 (1989)
19. George, L. L., Borody, T. J., Andrews, P., Med. J. Aust. 153, 145 (1990)
20. Hentschel, E., N. Engl. J. Med. 328, 308 (1993)
21. European Study Group on antibiotic susceptibility of H. pylori, Eur. J. Clin. Microbiol. Infect. Dis. 11, 1 (1992)
22. Arenas, J. J., An. Med. Interna 2, 304 (1994)